{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:15:33Z","timestamp":1784034933990,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.autrev.2012.02.015","type":"journal-article","created":{"date-parts":[[2012,2,27]],"date-time":"2012-02-27T18:30:54Z","timestamp":1330367454000},"page":"815-820","source":"Crossref","is-referenced-by-count":49,"title":["Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature"],"prefix":"10.1016","volume":"11","author":[{"given":"Elena","family":"Bartoloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Alunno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onelia","family":"Bistoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Bizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Migliorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Morozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milvia","family":"Lotzniker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Allegri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Riccieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Alpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilina","family":"Tampoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2012.02.015_bb0190","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria. An American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.015_bb0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.015_bb0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/art.30100","article-title":"Comparison of the 1987 American College of Rheumatology Criteria and the 2010 American College of Rheumatology\/European League against Rheumatism Criteria","volume":"63","author":"van der Liden","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.015_bb0020","first-page":"815038","article-title":"A systematic review of serum biomarkers anti-cyclic citrullinated peptide and rheumatoid factor as tests for rheumatoid arthritis","volume":"2011","author":"Taylor","year":"2011","journal-title":"Autoimmun Dis"},{"key":"10.1016\/j.autrev.2012.02.015_bb0025","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.autrev.2009.11.017","article-title":"Profiling of rheumatoid arthritis associated autoantibodies","volume":"9","author":"Conrad","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.02.015_bb0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.autrev.2010.08.009","article-title":"All you wanted to know about anti-CCP but were afraid to ask","volume":"10","author":"Wiik","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.02.015_bb0035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.autrev.2009.04.006","article-title":"Anti-citrullinated protein\/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis","volume":"9","author":"Szodoray","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.02.015_bb0040","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1136\/jclinpath-2011-200308","article-title":"Multicentric evaluation of a second assay to detect antiviral citrullinated peptide antibodies: a collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni","volume":"64","author":"Bizzaro","year":"2011","journal-title":"Clin Pathol"},{"key":"10.1016\/j.autrev.2012.02.015_bb0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2249.2011.04378.x","article-title":"Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies","volume":"164","author":"Pratesi","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2012.02.015_bb0050","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","article-title":"Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.02.015_bb0055","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.22817","article-title":"Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis","volume":"56","author":"Bang","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.015_bb0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.2008.103283","article-title":"Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review","volume":"69","author":"Luime","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.015_bb0065","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3899\/jrheum.101143","article-title":"Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide","volume":"38","author":"El-Barbary","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.015_bb0200","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/ard.2007.073718","article-title":"Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis","volume":"67","author":"Gerli","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.015_bb0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/ard.2009.113092","article-title":"Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study","volume":"69","author":"Syversen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.015_bb0080","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar2570","article-title":"Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy","volume":"10","author":"Roland","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.02.015_bb0085","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/art.24716","volume":"60","author":"van der Linden","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.015_bb0090","first-page":"85","article-title":"Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis","volume":"29","author":"Besada","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.015_bb0205","first-page":"1002","article-title":"Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides","volume":"35","author":"Innala","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.015_bb0100","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.3899\/jrheum.081263","article-title":"The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders","volume":"36","author":"Engelmann","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.015_bb0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/art.23188","article-title":"Antibodies against citrullinated vimentin in rheumatoid arthritis. Higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides","volume":"58","author":"Mathsson","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.015_bb0110","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00296-009-0854-2","article-title":"Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis","volume":"29","author":"Wagner","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2012.02.015_bb0115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1756-185X.2010.01552.x","article-title":"Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis","volume":"13","author":"Maraina","year":"2010","journal-title":"Intern J Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.015_bb0120","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jbspin.2010.02.007","article-title":"Presence and diagnostic performances of IgA class antibodies to mutated citrullinated vimentin in rheumatoid arthritis","volume":"77","author":"Sghiri","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2012.02.015_bb0125","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar2362","article-title":"Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study","volume":"10","author":"Ursum","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.02.015_bb0130","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3899\/jrheum.080796","article-title":"The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis","volume":"36","author":"Liu","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.015_bb0135","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/ard.2009.118448","article-title":"Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis","volume":"69","author":"Raza","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.015_bb0140","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.2009.108456","article-title":"Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis","volume":"69","author":"Damjanovska","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.015_bb0145","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3899\/jrheum.101086","article-title":"A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early rheumatoid arthritis","volume":"38","author":"Sv\u00e5rd","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.015_bb0150","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/ar2008","article-title":"Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis","volume":"8","author":"Dejaco","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.02.015_bb0215","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-011-2193-3","article-title":"Antibodies to mutated citrullinated vimentin in patients with chronic hepatitis C virus genotype IV infection-related arthrtopathy","author":"Zehairy","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2012.02.015_bb0220","article-title":"Autoantibodies in patients with chronic hepatitis C virus infection: pitfalls for the diagnosis of rheumatic diseases","author":"Palazzi","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.02.015_bb0165","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/carcin\/bgp313","article-title":"IQGAP1 and vimentin are key regulator genes in naturally occurring hepatotumorigenesis induced by oxidative stress","volume":"31","author":"Tsubota","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.autrev.2012.02.015_bb0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cgh.2009.10.034","article-title":"Histologic predictors of fibrosis progression in liver allografts in patients with hepatitis C virus infection","volume":"8","author":"Meriden","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2012.02.015_bb0175","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1373\/clinchem.2007.087569","article-title":"Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins","volume":"53","author":"Bizzaro","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2012.02.015_bb0180","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12016-009-8158-6","article-title":"Infectious aspects and the etiopathogenesis of rheumatoid arthritis","volume":"38","author":"Meron","year":"2010","journal-title":"Clin Rev Allerg Immunol"},{"key":"10.1016\/j.autrev.2012.02.015_bb0185","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.autrev.2009.01.013","article-title":"Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory","volume":"8","author":"Bossuyt","year":"2009","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212000432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212000432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T19:22:22Z","timestamp":1543173742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997212000432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1568997212000432"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2012.02.015","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}